RFP 2024.14 Portfolio Evaluation: Better tools for diagnosis and treatment of drug-resistant tuberculosis

RFP 2024.14 Portfolio Evaluation: Better tools for diagnosis and treatment of drug-resistant tuberculosis In order to access the Request for Proposal (RFP) documents, please log-in as a registered Supplier (Account registration accessible on https://www.ungm.org/Account/Registration). If Bidder experience difficulties in accessing the RFP documents after having registered and expressed interest, please send an email to: unitaid-proc@who.int Objective of the consultancy: To identify a suitable provider with relevant experience to conduct portfolio evaluation on Unitaid’s investments related to “Better tools for diagnosis and treatment of drug-resistant tuberculosis”. Qualification of Firm and Consultants: The successful bidders will propose a multi-disciplinary team of 3-4 experienced evaluators, including the team leader, that together bring a strong understanding of market dynamics and interventions to increase access to TB/DR-TB diagnosis and treatment in LMICs. The team leader must have at least 10 years of experience leading evaluations of a similar scope and complexity. Core team members should have at least five years of individual experience in their respective areas of technical expertise. The proposed evaluation team shall meet the following requirements: 1. Expert knowledge of TB and, in particular, the challenges related to testing, diagnosis and treatment of TB and DR-TB in LMICs; 2. Experience with mixed methods approaches, with at least one team member with expertise in collection and analysis of qualitative data; experience with outcome harvesting and contribution analysis or other comparable evaluation approaches desirable; 3. Expert knowledge of the global health landscape and the dynamics of introducing and scaling up interventions for complex health issues within existing health systems at national and global levels; 4. Experience in evaluating advocacy and community/civil society engagement, partnerships and demand creation interventions; 5. Regional and/or country presence in project countries or established network of local counterparts with an in-depth understanding of national and sub-national TB policy and implementation context; 6. At least one team member with expertise in clinical trials and implementation research; 7. Include an appropriate representation with regard to sex, a broad mix of backgrounds, skills and perspectives, and national and international experience, including in resource-limited settings; and 8. Proficiency in English (knowledge of other UN languages an asset); final deliverables must be submitted in English. Bidders are invited to submit a proposal for the above mentioned RFP in accordance to the documents attached in the "Tender Document" tab. Proposals must be submitted via UNGM, through the “RFP documents” tab and upload documents in “My Tender Return” no later than 17:00 hours Geneva time on 27 November 2024.